kConFab Letter of Intent Submissions
DateInvestigatorsAffiliationProject Title
November 2018
Pilot project
Dr Jessica Logan and Professor Doug Brooks Mechanisms in Cell Biology and Disease Research Group School of Pharmacy and Medical Sciences, Cancer Research Institute, University of South Australia Prostate Cancer Pathophysiology and Ovarian Cancer Pathophysiology
November 2018
Full project
Kate Nathanson, Susan Domchek and Georgia Chenevix-Trench University of Pennsylvania, USA and QIMR Brisbane Immunogenicity in BRCA1/2 mutation carriers
October 2018
Full application
Kara Maxwell et al University of Pennsylvania, USA Genotype-phenotype study of breast tumors from patients with Li-Fraumeni Syndrome
January 2019
Full project
Martha Hickey, Kelly Phillips and Karla Hutt The University of Melbourne, Monash University and The Peter MacCallum Cancer Centre, Melbourne Do BRCA1 and BRCA2 gene mutation carriers have decreased ovarian reserve?
January 2019
Pilot project
Ashok Venkitaraman and Mona Shehata University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK BRCA2 Haploinsufficiency and Genome Instability
January 2019
Full application
Robert G Bristow, Gail Risbridger et al CRUK Manchester Institute, United Kingdom and Monash University MBDI Institute & Peter MacCallum Cancer Centre, Melbourne Models of germline BRCA2-mutant prostate cancer
June 2019
Pilot application
Sarah-Jane Dawson The Peter MacCallum Cancer Centre , Melbourne Genomic alterations and methylation changes from plasma derived circulating tumour DNA in patients with cancer.

A pilot or full application must be made within 6 months of submitting the letter of intent. If more than six months has elapsed, a new letter of intent must be submitted prior to the full application.